Literature DB >> 32210403

Pathogenetic insights into young-onset Parkinson disease.

Anthony H V Schapira1, Huw R Morris2.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32210403     DOI: 10.1038/s41582-020-0343-5

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN: 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial.

Authors:  Stephen Mullin; Laura Smith; Katherine Lee; Gayle D'Souza; Philip Woodgate; Josh Elflein; Jenny Hällqvist; Marco Toffoli; Adam Streeter; Joanne Hosking; Wendy E Heywood; Rajeshree Khengar; Philip Campbell; Jason Hehir; Sarah Cable; Kevin Mills; Henrik Zetterberg; Patricia Limousin; Vincenzo Libri; Tom Foltynie; Anthony H V Schapira
Journal:  JAMA Neurol       Date:  2020-04-01       Impact factor: 18.302

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.